Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$233M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| LaBarre Michael J. | Oct 16, 2024 | Sell | 10,000 | $53.259 | $530,000 |
| LaBarre Michael J. | Oct 15, 2024 | Sell | 9,923 | $53.743 | $530,000 |
| LaBarre Michael J. | Oct 15, 2024 | Sell | 77 | $54.245 | $4,200 |
| Torley Helen | Oct 9, 2024 | Sell | 5,981 | $51.847 | $310,000 |
| Torley Helen | Oct 9, 2024 | Sell | 2,404 | $53.906 | $130,000 |
| Torley Helen | Oct 9, 2024 | Sell | 1,615 | $53.31 | $86,000 |
| Torley Helen | Oct 8, 2024 | Sell | 9,100 | $53.939 | $490,000 |
| Torley Helen | Oct 8, 2024 | Sell | 900 | $54.573 | $49,000 |
| Torley Helen | Sep 26, 2024 | Sell | 10,000 | $56.097 | $560,000 |
| LaBarre Michael J. | Sep 18, 2024 | Sell | 7,963 | $61.891 | $490,000 |
| LaBarre Michael J. | Sep 18, 2024 | Sell | 2,037 | $62.581 | $130,000 |
| LaBarre Michael J. | Sep 17, 2024 | Sell | 10,000 | $62.878 | $630,000 |
| Torley Helen | Sep 12, 2024 | Sell | 10,000 | $59.203 | $590,000 |
| LaBarre Michael J. | Aug 21, 2024 | Sell | 9,900 | $61.741 | $610,000 |
| LaBarre Michael J. | Aug 21, 2024 | Sell | 100 | $62.34 | $6,200 |
| LaBarre Michael J. | Aug 20, 2024 | Sell | 10,000 | $61.055 | $610,000 |
| Torley Helen | Aug 15, 2024 | Sell | 10,000 | $57.949 | $580,000 |
| Torley Helen | Aug 14, 2024 | Sell | 6,537 | $57.732 | $380,000 |
| Torley Helen | Aug 14, 2024 | Sell | 3,263 | $56.219 | $180,000 |
| Posard Matthew L. | Aug 14, 2024 | Sell | 9,881 | $57.7 | $570,000 |
| Torley Helen | Aug 14, 2024 | Sell | 200 | $58.17 | $12,000 |
| Posard Matthew L. | Aug 13, 2024 | Sell | 10,000 | $56.193 | $560,000 |
| LaBarre Michael J. | Jul 24, 2024 | Sell | 10,000 | $55.115 | $550,000 |
| LaBarre Michael J. | Jul 23, 2024 | Sell | 5,291 | $55.265 | $290,000 |
| LaBarre Michael J. | Jul 23, 2024 | Sell | 4,709 | $54.463 | $260,000 |
| LaBrosse Nicole | Jul 22, 2024 | Sell | 4,008 | $53.853 | $220,000 |
| LaBrosse Nicole | Jul 22, 2024 | Sell | 992 | $54.253 | $54,000 |
| LaBrosse Nicole | Jun 28, 2024 | Sell | 10,000 | $52.04 | $520,000 |
| LaBarre Michael J. | Jun 18, 2024 | Sell | 10,000 | $49.426 | $490,000 |
| Posard Matthew L. | Jun 12, 2024 | Sell | 10,000 | $50.619 | $510,000 |
| LaBarre Michael J. | May 22, 2024 | Sell | 10,000 | $45.384 | $450,000 |
| LaBarre Michael J. | Apr 17, 2024 | Sell | 10,000 | $38.489 | $380,000 |
| LaBarre Michael J. | Mar 13, 2024 | Sell | 10,000 | $42.273 | $420,000 |
| LaBarre Michael J. | Feb 28, 2024 | Sell | 7,471 | $39.542 | $300,000 |
| LaBarre Michael J. | Feb 28, 2024 | Sell | 2,529 | $39.559 | $100,000 |
| LaBarre Michael J. | Feb 27, 2024 | Sell | 10,000 | $39.946 | $400,000 |
| LaBarre Michael J. | Jan 17, 2024 | Sell | 10,000 | $36 | $360,000 |
| LaBarre Michael J. | Dec 13, 2023 | Sell | 10,000 | $40.394 | $400,000 |
| LaBarre Michael J. | Dec 12, 2023 | Sell | 9,357 | $39.575 | $370,000 |
| LaBarre Michael J. | Dec 12, 2023 | Sell | 643 | $40.465 | $26,000 |
| LaBarre Michael J. | Nov 15, 2023 | Sell | 10,000 | $39.788 | $400,000 |
| LaBarre Michael J. | Nov 14, 2023 | Sell | 8,292 | $39.079 | $320,000 |
| LaBarre Michael J. | Nov 14, 2023 | Sell | 1,708 | $39.079 | $67,000 |
| LaBarre Michael J. | Oct 17, 2023 | Sell | 10,000 | $36.52 | $370,000 |
| LaBarre Michael J. | Sep 19, 2023 | Sell | 10,000 | $39.098 | $390,000 |
| Torley Helen | Aug 31, 2023 | Sell | 10,000 | $42.817 | $430,000 |
| LaBarre Michael J. | Aug 22, 2023 | Sell | 8,075 | $42.407 | $340,000 |
| LaBarre Michael J. | Aug 22, 2023 | Sell | 1,925 | $42.407 | $82,000 |
| Torley Helen | Aug 17, 2023 | Sell | 10,000 | $43.182 | $430,000 |
| Daly James M | Aug 14, 2023 | Sell | 10,000 | $43.741 | $440,000 |
| Torley Helen | Jul 27, 2023 | Sell | 10,000 | $43.79 | $440,000 |
| LaBarre Michael J. | Jul 18, 2023 | Sell | 10,000 | $40.43 | $400,000 |
| LaBarre Michael J. | Jun 21, 2023 | Sell | 10,000 | $36 | $360,000 |
| LaBarre Michael J. | Apr 18, 2023 | Sell | 10,000 | $36 | $360,000 |
| Torley Helen | Mar 9, 2023 | Sell | 10,000 | $42.727 | $430,000 |
| Henderson Jeffrey William | Mar 1, 2023 | Sell | 10,000 | $47.71 | $480,000 |
| LaBarre Michael J. | Feb 27, 2023 | Sell | 7,016 | $49.548 | $350,000 |
| LaBarre Michael J. | Feb 27, 2023 | Sell | 2,984 | $49.549 | $150,000 |
| Torley Helen | Feb 16, 2023 | Sell | 11,061 | $49.26 | $540,000 |
| LaBarre Michael J. | Feb 16, 2023 | Sell | 2,878 | $49.26 | $140,000 |
| LaBrosse Nicole | Feb 16, 2023 | Sell | 2,525 | $49.26 | $120,000 |
| LaBarre Michael J. | Feb 15, 2023 | Sell | 10,000 | $48.394 | $480,000 |
| Torley Helen | Feb 9, 2023 | Sell | 10,000 | $50.4 | $500,000 |
| Torley Helen | Jan 19, 2023 | Sell | 10,000 | $52.414 | $520,000 |
| Torley Helen | Jan 17, 2023 | Sell | 8,897 | $50.395 | $450,000 |
| Torley Helen | Jan 17, 2023 | Sell | 1,103 | $50.929 | $56,000 |
| LaBarre Michael J. | Jan 17, 2023 | Sell | 8,878 | $50.4 | $450,000 |
| LaBarre Michael J. | Jan 17, 2023 | Sell | 1,122 | $50.926 | $57,000 |
What's the latest insider transaction for Halozyme Therapeutics?
The most recent insider transaction for Halozyme Therapeutics was conducted by LaBarre Michael J., who sold 10,000 shares on October 16, 2024 at a price of $53.26 per share.
Which insider has sold the most HALO stock over the last two years?
LaBarre Michael J. has sold the most HALO stock in the last 2 years, with a total value of $13M.
What is the total value of insider transactions for Halozyme Therapeutics (HALO) in the last 2 years?
The total value of insider transactions for Halozyme Therapeutics in the last 2 years is negative, amounting to -$24M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Halozyme Therapeutics' market confidence?
Over the last 2 years, insider transactions for Halozyme Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
